Nanobiotechnology in Diagnosis, Drug Delivery and Treatment. Группа авторов

in vivo fluorescent imaging of colorectal cancer models. Nanomedicine (London, England) 10: 1223–1231.

      77 Tokajuk, G., Niemirowicz, K., Deptuła, P. et al. (2017). Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity. International Journal of Nanomedicine 12: 7833–7846.

      78 Torchilin, V.P. (2007). Targeted pharmaceutical nanocarriers for cancer therapy and imaging. The AAPS Journal 9: E128–E147.

      79 Umamaheshwari, R.B. and Jain, N.K. (2003). Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. Journal of Drug Targeting 11: 415–424.

      80 Vigor, K.L., Kyrtatos, P.G., Minogue, S. et al. (2010). Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 31: 1307–1315.

      81 Viswanath, B., Kim, S., and Lee, K. (2016). Recent insights into nanotechnology development for detection and treatment of colorectal cancer. International Journal of Nanomedicine 11: 2491–2504.

      82 Walczak, A.P., Fokkink, R., Peters, R. et al. (2013). Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model. Nanotoxicology 7: 1198–1210.

      83 Walczak, A.P., Kramer, E., Hendriksen, P.J. et al. (2015). In vitro gastrointestinal digestion increases the translocation of polystyrene nanoparticles in an in vitro intestinal co‐culture model. Nanotoxicology 9: 886–894.

      84 Weinberg, W.C., Frazier‐Jessen, M.R., Wu, W.J. et al. (2005). Development and regulation of monoclonal antibody products: challenges and opportunities. Cancer Metastasis Reviews 24: 569–584.

      85 Weissleder, R., Kelly, K., Sun, E.Y. et al. (2005). Cell‐specific targeting of nanoparticles by multivalent attachment of small molecules. Nature Biotechnology 23: 1418–1423.

      86  Westmeier, D., Posselt, G., Hahlbrock, A. et al. (2018). Nanoparticle binding attenuates the pathobiology of gastric cancer‐associated Helicobacter pylori. Nanoscale 10: 1453–1463.

      87 Xiao, B. and Merlin, D. (2012). Oral colon‐specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opinion in Drug Delivery 9: 1393–1407.

      88 Zhu, X. and Gao, T. (2019). Spectrometry. In: Nano‐Inspired Biosensors for Protein Assay with Clinical Applications (ed. G. Li), 237–264. Amsterdam, Netherlands: Elsevier.

      89 Zottel, A., Videtič, A., and Jovcevska, A. (2019). Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy. Materials 12: 1–28.